Next-Generation Immunotherapies for Relapsed/Refractory Multiple Myeloma (RRMM): Integrating Costimulatory Bispecific Antibody (bsAb) Signaling

Speaker(s)

• 

  Glenn S. Kroog, MD (he/him/his)

  Executive Medical Director
  Regeneron Pharmaceuticals, Inc
  Tarrytown, New York